Receive our newsletter – data, insights and analysis delivered to you
  1. News
June 20, 2016

Great Basin introduces enhanced molecular diagnostic analyser

US-based molecular diagnostics company Great Basin Scientific has introduced its enhanced molecular diagnostic analyser, GB550, at the American Society for Microbiology Microbe conference in Boston.

Great Basin

US-based molecular diagnostics company Great Basin Scientific has introduced its enhanced molecular diagnostic analyser, GB550, at the American Society for Microbiology Microbe conference in Boston.

GB550 will enable lab technicians to conduct tests within 75-90 minutes and sometimes in less than an hour.

It features an integrated touchscreen and barcode scanner which assists in decreasing the overall footprint and negates the requirement of external cables.

The analyser consists of a convenient software interface which can be compatible with all the existing and future Great Basin developed tests and panels, including the company’s tests for Toxigenic Clostridium difficile (C. diff), Group B Streptococcus (GBS), as well as the newly cleared Shiga Toxin Direct Test and the Staph ID/R Blood Culture Panel.

"Our customers will enjoy the smaller footprint, improved ease-of-use and reduced test time."

Great Basin Scientific co-founder and CEO Ryan Ashton said: "We are pleased with the ongoing improvements we have made to our original instrument and how those efforts have informed the design of the GB550.

"Our customers will enjoy the smaller footprint, improved ease-of-use and reduced test time, which we believe will make our system even more attractive to a wider variety of users that, in turn, will allow us to expand our footprint of installed sites.

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment

"And, important to our business model, the ability for improved productivity per analyser increases the Company’s potential revenue per instrument by 35-40%."

Great Basin is anticipating the delivery of thedevice early next year at no cost to the customer, with no minimum volume commitment and no contracts.


Image: Great Basin’s molecular diagnostic analyser, GB550. Photo: courtesy of Business Wire.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU